NDC51407-0121-01: METHOTREXATE TABLETS.
The METHOTREXATE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.0 TABLETS, active_medicament_medicinal_strength: 2.50 MILLIGRAMS METHOTREXATE EQUIVALENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-661-9048, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.0 TABLETS |
| active_medicament_medicinal_strength | 2.50 MILLIGRAMS METHOTREXATE EQUIVALENT |
| part_name_assigned_by_controlling_agency | METHOTREXATE SODIUM TABLETS, 2.5MG, 100S |
| NSN | 6505-01-661-9048 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.0 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | EACH TABLET FOR ORAL ADMINISTRATION, CONTAINS METHOTREXATE SODIUM EQUIVALENT TO 2.5 MILLIGRAMS (MG) OF METHOTREXATE, USP. STRENGTH: 2.5 MG; STORE AT 20 TO 25 C (68 TO 77 F); (SEE USP CONTROLLED ROOM TEMPERATURE); REPLACEMENT FOR NSN 6505-00-963-5353 |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | METHOTREXATE SODIUM TABLETS, 2.5MG, 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.50 MILLIGRAMS METHOTREXATE EQUIVALENT |